COMMUNIQUÉS West-GlobeNewswire

Lexington Recieves Approval to Commence Clinical Study
24/01/2018
VANCOUVER, British Columbia, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to announce its [...]
Aterica Licenses mMed Patent Portfolio to Expand Application of its Digital Health Platform and Advance its Digital Health Initiatives for Individuals and Families
24/01/2018
WATERLOO, Ontario, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Aterica Inc. has entered into an agreement with New Directions Technology Consulting, LLC ( NDTC ) as the exclusive licensee of the mMed Patent Portfolio . This [...]
MRI Interventions Recognizes FDA Clearance of Voyager’s Investigational New Drug Application for VY-AADC Allowing its Pivotal Program to Begin for Advanced Parkinson’s Disease
24/01/2018
IRVINE, Calif., Jan. 24, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today commented on Voyager Therapeutics’ announcement of FDA clearance of its Investigational New Drug (IND) application for VY-AADC [...]
CV Sciences, Inc. to Exhibit and Present at the 2018 Integrative Health Symposium Annual Conference in New York, New York – February 22-24, 2018
24/01/2018
LAS VEGAS, Jan. 24, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), today announced that it will be exhibiting its industry-dominating brand of hemp-derived CBD oil [...]
Assure Holdings Corp. Names Alex Rasmussen as Executive Vice President of Operations
24/01/2018
PARKER, Colo., Jan. 24, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV:IOM) (OTCQB:ARHH), a provider of intraoperative neuromonitoring services, has appointed Alex Rasmussen to the [...]
Treos Bio Announces FDA Approval of IND of Its First PolyPEPI™ Precision Cancer Vaccine for Metastatic Colorectal Cancer
24/01/2018
SAN FRANCISCO and LONDON, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Treos Bio Limited, an immuno-oncology company developing next-generation, off-the-shelf precision cancer vaccines coupled with companion diagnostics, today [...]
GPS SmartSoles Available for Sale on Amazon
24/01/2018
LOS ANGELES, Jan. 24, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO ) , an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive technology business, announced today [...]
Medtronic Launches ENCHANT Study to Evaluate ChEVAR Parallel Graft Technique with the Endurant(TM) II/IIs Stent Graft System
24/01/2018
Clinical Study to Investigate the Performance of the ChEVAR Technique in AAA Patients with Short Aortic Necks DUBLIN - January 24, 2018 - Medtronic plc (NYSE: MDT) today announced the launch of the ENCHANT ( EN durant [...]
Fibrocell to Present at Phacilitate Cell and Gene Therapy World 2018
24/01/2018
EXTON, Pa., Jan. 24, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]
Treatment Commences in Second Patient Cohort in Cynata’s World First Clinical Trial
24/01/2018
MELBOURNE, Australia, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX:CYP), is pleased to announce that the first patient in Cohort B has been [...]
Sorrento Therapeutics CAR-T Manufacturing Capacity Expanded With Opening of East Coast GMP Site in Addition to Primary West Coast Facility
24/01/2018
SAN DIEGO, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today the expansion of its Good Manufacturing Practices (GMP) CAR-T manufacturing capacity, with an [...]
CASMED Submits FORE-SIGHT® OEM Module 510(k) to FDA
24/01/2018
BRANFORD, Conn., Jan. 24, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a leader in non-invasive cerebral oximetry patient monitoring, announces that it has submitted a 510(k) application [...]
VitalHub Subsidiary B Sharp Technologies Signs Strategic Deal to Provide More Children Access to Critical Mental Health Support in Canada
24/01/2018
TORONTO, Jan. 24, 2018 (GLOBE NEWSWIRE) -- B Sharp Technologies, a subsidiary of VitalHub Corp. (“VitalHub”) (TSXV:VHI), has signed a strategic reseller agreement with TELUS Health to distribute a white-labelled version [...]
Helius Medical Technologies and US Army Research Laboratory Launch Additional PoNS® Research
24/01/2018
NEWTOWN, Pa., Jan. 24, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, [...]
Immunovaccine Named to 2018 OTCQX Best 50
24/01/2018
HALIFAX, Nova Scotia, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that it has been named to the 2018 OTCQX® Best 50 , a [...]
IntelGenx Initiates Phase 2A Montelukast Versafilm™ Clinical Trial in Alzheimer’s Patients
24/01/2018
SAINT-LAURENT, Quebec, Jan. 24, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx") is pleased to announce that it has initiated the Phase 2a proof of concept (“POC”) [...]
Intellipharmaceutics Provides Operational Update
24/01/2018
TORONTO, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq: IPCI ) (TSX: IPCI ) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, [...]
Santhera Anticipates Receiving a Negative CHMP Opinion on Appeal for Marketing Authorization Application for Raxone® in Duchenne Muscular Dystrophy
24/01/2018
Liestal, Switzerland, January 24, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that on January 23 it had an oral explanation at the Committee for Medicinal Products for Human Use (CHMP) of the European [...]
Exalenz Bioscience Announces Positive Clinical Trial Results For the Diagnosis of Clinically Significant Portal Hypertension in NASH Patients
24/01/2018
Easy-to-administer, noninvasive BreathID ® test offers multiple advantages over alternative invasive detection methods Potential 2020 entry to an addressable U.S. market of millions of NASH patients MODI’IN, ISRAEL and [...]

Pages